Role of the TRF2 telomeric protein in cancer and ageing

Cell Cycle

Volumn 5, Issue 7, 2006, Pages 718-721

  Muñoz, Purificación ^a   Blanco, Raquel ^a   Blasco, María A ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

Aging; Cancer; Mouse models; Telomere binding proteins; Telomeres; TRF2

Indexed keywords

DNA POLYMERASE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; NUCLEASE; REPETITIVE DNA; TELOMERASE; TELOMERIC REPEAT BINDING FACTOR 2;

AGING; CANCER; CARCINOGENESIS; CELL DEATH; CELL VIABILITY; CHROMOSOME; CHROMOSOME SIZE; DISEASE ASSOCIATION; DISEASE MODEL; DNA DEGRADATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENETIC RECOMBINATION; GENETICS; HETEROCHROMATIN; HOMEOSTASIS; HUMAN; MORPHOLOGY; NONHUMAN; PATHOLOGY; PREMATURE AGING; PROTECTION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SYNDROME; TELOMERE; TISSUE;

EID: 33645710018     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.5.7.2636     Document Type: Review

References (19)

1. De Lange T. Protection of mammalian telomeres. Oncogene 2002; 21:532-40.
2. Blackburn EH. Switching and signaling at the telomere. Cell 2001; 106:661-73.
3. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19:2100-10.
4. Karlseder J, Kachatrian L, Takai H, Mercer K, Hingorani S, Jacks T, de Lange T. Targeted deletion reveals an essential function for the telomere length regulator Trf1. Mol Cell Biol 2003; 23:6533-41.
5. Dynek JN and Smith S. Resolution of sister telomere association is required for progression through mitosis. Science 2004; 304:97-100.
6. Prime G, and Markie D. The telomere repeat binding protein Trf1 interacts with the spindle checkpoint protein Mad1 and Nek2 mitotic kinase. Cell Cycle 2005; 4:121-4.
7. Blasco MA. Telomeres and human disease: cancer, ageing and beyond. Nature Reviews Genetics 2005; 6:611-22.
8. Muñoz P, Blanco R, Flores JM and Blasco MA. XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer. Nature Genetics 2005;10:1063-71.
9. Samper E, Flores JM & Blasco MA. Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc-/- mice with short telomeres. EMBO Reports 2001; 2:1-8.
10. de Laat WL, Jaspers NG and Hoeijmakers JH. Molecular mechanism of nucleotide excision repair. Genes Dev 1999; 13:768-85.
11. Zhu XD, Niedernhofer L, Kuster B, Mann M, Hoeijmakers JH, de Lange T. ERCC1/XPF removes the 3' overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol Cell 2003; 12:1489-98.
12. de Boer J and Hoeijmakers JH. Nucleotide excision repair and human syndromes. Carcinogenesis 2000; 21:453-60.
13. Blasco MA and Hahn WC. Evolving views of telomerase and cancer. Trends Cell Biol 2003; 13:289-94.
14. Gonzalez-Suarez E, Samper E, Flores JM, Blasco MA. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet 2000; 26:114-7.
15. Karlseder J, Hoke K, Mirzoeva OK, Bakkenist C, Kastan MB, Petrini JH, de Lange T. The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response. PLoS Biol 2004; 2:E240.
16. Bradshaw PS, Stavropoulos DJ and Meyn MS. Human telomeric protein TRF2 associates with genomic double-strand breaks as an early response to DNA damage. Nat Genet 2005; 37:193-7.
17. Jacobs JJL and de Lange T. p16INK4a as a second effector of the telomere damage pathway. Cell Cycle 2005; 4:1364-8.
18. Oh B-K, Kim Y-J, Park C and Park YN. Up-regulation fo telomere-binding proteins, TRF1, TRF2 and TIN2 is related to telomere shortening during human multistep heptocarcinogenesis. Am J Pathol 2005; 166:73-80.
19. Matsutani N, Yokozaki H, Tahara E, Tahara H, Kuniyasu H, Haruma K, Chayama K, Yasui W, Tahara E. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas. Int J Oncol 2001; 19:507-12.